A Label-Free blocking immunoassay to evaluate Anti-Adalimumab antibody activity in clinical samples
{{output}}
Background: Adalimumab (ADL), a monoclonal antibody targeting TNF-⍺, is widely used to treat autoimmune diseases, but its efficacy can diminish over time due to the development of antidrug antibodies (ADAs), particularly neutral... ...
